BAKER BROS. ADVISORS LP

Holdings History for Prelude Therapeutics Inc - Common Stock, par value $0.0001 per share (PRLD)

Symbol: PRLD on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 10,269,968 shares
Security Ownership %: 24%

Shares, Excluding Options vs Price

Value, Excluding Options

Baker Bros. Advisors LP ownership in Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD)

13 Jun 2025 - Baker Bros. Advisors LP has filed an SCHEDULE 13D/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 10,269,968 shares of Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD). This represents 24% ownership of the company. This is the first filing by BAKER BROS. ADVISORS LP disclosing ownership of Prelude Therapeutics Inc Common Stock, par value $0.0001 per share (PRLD).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
Baker Bros. Advisors LP	24%		$8,010,575	10,269,968			$0.78	13D/A	12 Jun 2025	13 Jun 2025, 17:21

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0.17%	0%	$29,359,090	10,123,824	0		$2.90	Q4 2025
30 Sep 2025	0.11%	0%	$14,578,307	10,123,824	0		$1.44	Q3 2025
30 Jun 2025	0.08%	0%	$8,194,223	10,123,824	0		$0.81	Q2 2025
31 Mar 2025	0.09%	0%	$7,775,097	10,123,824	0		$0.77	Q1 2025
31 Dec 2024	0.14%	0%	$12,907,876	10,123,824	0		$1.28	Q4 2024
30 Sep 2024	0.22%	0%	$20,956,316	10,123,824	0		$2.07	Q3 2024
30 Jun 2024	0.49%	0%	$38,571,769	10,123,824	0		$3.81	Q2 2024
31 Mar 2024	0.6%	0%	$47,986,926	10,123,824	0		$4.74	Q1 2024
31 Dec 2023	0.49%	0%	$43,228,728	10,123,824	0		$4.27	Q4 2023
30 Sep 2023	0.18%	0%	$31,282,616	10,123,824	0		$3.09	Q3 2023
30 Jun 2023	0.26%	0%	$45,557,208	10,123,824	0		$4.50	Q2 2023
31 Mar 2023	0.31%	0%	$57,705,797	10,123,824	0		$5.70	Q1 2023
31 Dec 2022	0.37%	0%	$61,147,897	10,123,824	0		$6.04	Q4 2022
30 Sep 2022	0.44%	0%	$66,918,000	10,123,824	0		$6.61	Q3 2022
30 Jun 2022	0.3%	0%	$52,846,000	10,123,824	0		$5.22	Q2 2022
31 Mar 2022	0.4%	0%	$69,854,000	10,123,824	0		$6.90	Q1 2022
31 Dec 2021	0.61%	0%	$126,042,000	10,123,824	0		$12.45	Q4 2021
30 Sep 2021	1.4%	0%	$316,370,000	10,123,824	0		$31.25	Q3 2021
30 Jun 2021	1.3%	0%	$289,845,000	10,123,824	0		$28.63	Q2 2021
31 Mar 2021	1.9%	+0%	$438,665,000	10,123,824	+5,188	+0.05%	$43.33	Q1 2021
31 Dec 2020	2.7%	0%	$723,988,000	10,118,636	0		$71.55	Q4 2020
30 Sep 2020	1.2%	+1.2%	$304,875,000	10,118,636	+10,118,636	NEW	$30.13	Q3 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.